Definium Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference

NEW YORK — Definium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that members of the Company’s management team will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference in New York on... The post Definium Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference appeared first on Montreal Gazette .

Original source: Montreal Gazette